{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T21:08:02Z","timestamp":1780607282735,"version":"3.54.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T00:00:00Z","timestamp":1677110400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004731","name":"Zhejiang Provincial Natural Science Foundation","doi-asserted-by":"crossref","award":["No. LTGD23H090002"],"award-info":[{"award-number":["No. LTGD23H090002"]}],"id":[{"id":"10.13039\/501100004731","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Obesity is a widely recognized driving factor of Non-alcoholic fatty liver disease (NAFLD), it remains unclear whether historical weight status was associated with the presence of NAFLD. The study aimed to explore the relationship between weight change across adulthood and the presence of NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Data from the National Health and Nutrition Examination Survey III included 6586 participants. Weight change was assessed according to body mass index (BMI) at baseline, at 25\u00a0years old, and 10\u00a0years before baseline. Obesity was defined as BMI\u2009\u2265\u200930\u00a0kg\/m<jats:sup>2<\/jats:sup>. NAFLD was assessed by hepatic ultrasonography.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The prevalence of NAFLD was highest among stable obese participants (48.1%), and the lowest among stable non-obese participants (18.9%). Among non-obese participants, those who get obese in early adulthood had a higher risk for the presence of NAFLD than those who were never obese (odds ratio [OR], 1.82; 95% confidence interval [CI] 1.17\u20132.92). Among obese participants, those who become obese in middle-late adulthood had a lower risk of NAFLD (OR, 0.79; 95% CI 0.65\u20130.96) than those with stable obesity. A weight gain of more than 12\u00a0kg and 4\u00a0kg since early and middle-late adulthood respectively were associated with increased risks of NAFLD.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Among current nonobese individuals, those with a history of obesity in their early adulthood had a higher risk of NAFLD than those never obese. Among the currently obese population, those who became obese after mid-adulthood have a significantly lower risk of NAFLD compared with those who were stable obese.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12967-023-04007-8","type":"journal-article","created":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T15:03:02Z","timestamp":1677164582000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Weigh change across adulthood is related to the presence of NAFLD: results from NHANES III"],"prefix":"10.1186","volume":"21","author":[{"given":"Lili","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajun","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5212-7749","authenticated-orcid":false,"given":"Xiangpeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,23]]},"reference":[{"key":"4007_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/hep.28431","volume":"64","author":"ZM Younossi","year":"2016","unstructured":"Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64:73\u201384.","journal-title":"Hepatology"},{"key":"4007_CR2","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1002\/hep.29367","volume":"67","author":"N Chalasani","year":"2018","unstructured":"Chalasani N, Younossi Z, Lavine JE, Charlton M, Cusi K, Rinella M, Harrison SA, et al. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American association for the study of liver diseases. Hepatology. 2018;67:328\u201357.","journal-title":"Hepatology"},{"key":"4007_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","volume":"15","author":"Z Younossi","year":"2018","unstructured":"Younossi Z, Anstee QM, Marietti M, Hardy T, Henry L, Eslam M, George J, et al. Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention. Nat Rev Gastroenterol Hepatol. 2018;15:11\u201320.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4007_CR4","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1001\/jama.2015.5370","volume":"313","author":"ME Rinella","year":"2015","unstructured":"Rinella ME. Nonalcoholic fatty liver disease: a systematic review. JAMA. 2015;313:2263\u201373.","journal-title":"JAMA"},{"key":"4007_CR5","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.metabol.2018.11.014","volume":"92","author":"SA Polyzos","year":"2019","unstructured":"Polyzos SA, Kountouras J, Mantzoros CS. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics. Metabolism. 2019;92:82\u201397.","journal-title":"Metabolism"},{"key":"4007_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21218138","author":"J Hyun","year":"2020","unstructured":"Hyun J, Jung Y. DNA methylation in nonalcoholic fatty liver disease. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21218138.","journal-title":"Int J Mol Sci"},{"key":"4007_CR7","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1073\/pnas.1515472113","volume":"113","author":"A Stokes","year":"2016","unstructured":"Stokes A, Preston SH. Revealing the burden of obesity using weight histories. Proc Natl Acad Sci USA. 2016;113:572\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"key":"4007_CR8","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1038\/ijo.2010.41","volume":"34","author":"DD Ingram","year":"2010","unstructured":"Ingram DD, Mussolino ME. Weight loss from maximum body weight and mortality: the third national health and nutrition examination survey linked mortality file. Int J Obes. 2010;34:1044\u201350.","journal-title":"Int J Obes"},{"key":"4007_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1097\/EDE.0b013e3181b5f520","volume":"20","author":"M Myrskyl\u00e4","year":"2009","unstructured":"Myrskyl\u00e4 M, Chang VW. Weight change, initial BMI, and mortality among middle\u2014and older-aged adults. Epidemiology. 2009;20:840\u20138.","journal-title":"Epidemiology"},{"key":"4007_CR10","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1093\/aje\/kwt179","volume":"178","author":"H Zheng","year":"2013","unstructured":"Zheng H, Tumin D, Qian Z. Obesity and mortality risk: new findings from body mass index trajectories. Am J Epidemiol. 2013;178:1591\u20139.","journal-title":"Am J Epidemiol"},{"key":"4007_CR11","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1161\/CIRCRESAHA.115.306883","volume":"118","author":"FB Ortega","year":"2016","unstructured":"Ortega FB, Lavie CJ, Blair SN. Obesity and cardiovascular disease. Circ Res. 2016;118:1752\u201370.","journal-title":"Circ Res"},{"key":"4007_CR12","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1161\/01.CIR.71.3.481","volume":"71","author":"T Nakajima","year":"1985","unstructured":"Nakajima T, Fujioka S, Tokunaga K, Hirobe K, Matsuzawa Y, Tarui S. Noninvasive study of left ventricular performance in obese patients: influence of duration of obesity. Circulation. 1985;71:481\u20136.","journal-title":"Circulation"},{"key":"4007_CR13","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/ije\/dyr018","volume":"40","author":"A Abdullah","year":"2011","unstructured":"Abdullah A, Wolfe R, Stoelwinder JU, de Courten M, Stevenson C, Walls HL, Peeters A. The number of years lived with obesity and the risk of all-cause and cause-specific mortality. Int J Epidemiol. 2011;40:985\u201396.","journal-title":"Int J Epidemiol"},{"key":"4007_CR14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.l5584","volume":"367","author":"C Chen","year":"2019","unstructured":"Chen C, Ye Y, Zhang Y, Pan XF, Pan A. Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study. BMJ. 2019;367: l5584.","journal-title":"BMJ"},{"key":"4007_CR15","unstructured":"Third National Health and Nutrition Examination Survey: gallbladder ultrasonography procedure manual. In; September. 1988."},{"key":"4007_CR16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.metabol.2014.10.017","volume":"64","author":"SA Polyzos","year":"2015","unstructured":"Polyzos SA, Mantzoros CS. Leptin in health and disease: facts and expectations at its twentieth anniversary. Metabolism. 2015;64:5\u201312.","journal-title":"Metabolism"},{"key":"4007_CR17","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","volume":"397","author":"EE Powell","year":"2021","unstructured":"Powell EE, Wong VW, Rinella M. Non-alcoholic fatty liver disease. Lancet. 2021;397:2212\u201324.","journal-title":"Lancet"},{"key":"4007_CR18","doi-asserted-by":"publisher","first-page":"15080","DOI":"10.1038\/nrdp.2015.80","volume":"1","author":"EM Brunt","year":"2015","unstructured":"Brunt EM, Wong VWS, Nobili V, Day CP, Sookoian S, Maher JJ, Bugianesi E, et al. Nonalcoholic fatty liver disease. Nat Rev Dis Primers. 2015;1:15080.","journal-title":"Nat Rev Dis Primers"},{"key":"4007_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000001480","volume":"94","author":"CJ Pirola","year":"2015","unstructured":"Pirola CJ, Scian R, Gianotti TF, Dopazo H, Rohr C, Martino JS, Casta\u00f1o GO, et al. Epigenetic modifications in the biology of nonalcoholic fatty liver disease: the role of DNA hydroxymethylation and TET proteins. Medicine. 2015;94: e1480.","journal-title":"Medicine"},{"key":"4007_CR20","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/j.1582-4934.2010.01128.x","volume":"15","author":"J Carabelli","year":"2011","unstructured":"Carabelli J, Burgue\u00f1o AL, Rosselli MS, Gianotti TF, Lago NR, Pirola CJ, Sookoian S. High fat diet-induced liver steatosis promotes an increase in liver mitochondrial biogenesis in response to hypoxia. J Cell Mol Med. 2011;15:1329\u201338.","journal-title":"J Cell Mol Med"},{"key":"4007_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003387","volume":"17","author":"T Norris","year":"2020","unstructured":"Norris T, Cole TJ, Bann D, Hamer M, Hardy R, Li L, Ong KK, et al. Duration of obesity exposure between ages 10 and 40 years and its relationship with cardiometabolic disease risk factors: a cohort study. PLoS Med. 2020;17: e1003387.","journal-title":"PLoS Med"},{"key":"4007_CR22","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.2337\/dc17-2336","volume":"41","author":"A Stokes","year":"2018","unstructured":"Stokes A, Collins JM, Grant BF, Scamuffa RF, Hsiao CW, Johnston SS, Ammann EM, et al. Obesity progression between young adulthood and midlife and incident diabetes a retrospective cohort study of US adults. Diabetes Care. 2018;41:1025\u201331.","journal-title":"Diabetes Care"},{"key":"4007_CR23","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1093\/aje\/kwt254","volume":"179","author":"KF Adams","year":"2014","unstructured":"Adams KF, Leitzmann MF, Ballard-Barbash R, Albanes D, Harris TB, Hollenbeck A, Kipnis V. Body mass and weight change in adults in relation to mortality risk. Am J Epidemiol. 2014;179:135\u201344.","journal-title":"Am J Epidemiol"},{"key":"4007_CR24","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1056\/NEJMoa0807265","volume":"360","author":"K Bibbins-Domingo","year":"2009","unstructured":"Bibbins-Domingo K, Pletcher MJ, Lin F, Vittinghoff E, Gardin JM, Arynchyn A, Lewis CE, et al. Racial differences in incident heart failure among young adults. N Engl J Med. 2009;360:1179\u201390.","journal-title":"N Engl J Med"},{"key":"4007_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1002\/oby.23436","volume":"30","author":"X Wang","year":"2022","unstructured":"Wang X, Lu J, Gao Y, Song J, Li Y, Hundei W, Han Y, et al. Dose-response association between long-term weight loss in young adults and later-life metabolic health. Obesity. 2022;30:1289\u201397.","journal-title":"Obesity"},{"key":"4007_CR26","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1053\/j.gastro.2015.04.005","volume":"149","author":"E Vilar-Gomez","year":"2015","unstructured":"Vilar-Gomez E, Martinez-Perez Y, Calzadilla-Bertot L, Torres-Gonzalez A, Gra-Oramas B, Gonzalez-Fabian L, Friedman SL, et al. Weight loss through lifestyle modification significantly reduces features of nonalcoholic steatohepatitis. Gastroenterology. 2015;149:367-378.e365.","journal-title":"Gastroenterology"},{"key":"4007_CR27","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1016\/j.jhep.2018.08.011","volume":"69","author":"VW Wong","year":"2018","unstructured":"Wong VW, Wong GL, Chan RS, Shu SS, Cheung BH, Li LS, Chim AM, et al. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease. J Hepatol. 2018;69:1349\u201356.","journal-title":"J Hepatol"},{"key":"4007_CR28","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.cgh.2014.08.039","volume":"13","author":"NS Patel","year":"2015","unstructured":"Patel NS, Doycheva I, Peterson MR, Hooker J, Kisselva T, Schnabl B, Seki E, et al. Effect of weight loss on magnetic resonance imaging estimation of liver fat and volume in patients with nonalcoholic steatohepatitis. Clin Gastroenterol Hepatol. 2015;13:561-568.e561.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4007_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2020.154455","volume":"115","author":"DA Koutoukidis","year":"2021","unstructured":"Koutoukidis DA, Koshiaris C, Henry JA, Noreik M, Morris E, Manoharan I, Tudor K, et al. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: a systematic review and meta-analysis. Metabolism. 2021;115: 154455.","journal-title":"Metabolism"},{"key":"4007_CR30","doi-asserted-by":"publisher","first-page":"e529","DOI":"10.1097\/MEG.0000000000002158","volume":"33","author":"DH Sinn","year":"2021","unstructured":"Sinn DH, Kang D, Cho SJ, Paik SW, Guallar E, Cho J, Gwak GY. Weight change and resolution of fatty liver in normal weight individuals with nonalcoholic fatty liver disease. Eur J Gastroenterol Hepatol. 2021;33:e529\u201334.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"4007_CR31","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.diabres.2016.04.047","volume":"116","author":"S Du","year":"2016","unstructured":"Du S, Wang C, Jiang W, Li C, Li Y, Feng R, Sun C. The impact of body weight gain on nonalcoholic fatty liver disease and metabolic syndrome during earlier and later adulthood. Diabetes Res Clin Pract. 2016;116:183\u201391.","journal-title":"Diabetes Res Clin Pract"},{"key":"4007_CR32","doi-asserted-by":"publisher","first-page":"733","DOI":"10.14309\/ajg.0000000000001030","volume":"116","author":"G Yamada","year":"2021","unstructured":"Yamada G, Hagiwara Y, Kimura T, Takeuchi Y, Oba K, Masuda K, Matsuyama Y. Impact of body weight gain on the incidence of nonalcoholic fatty liver disease in nonobese japanese individuals. Am J Gastroenterol. 2021;116:733\u201340.","journal-title":"Am J Gastroenterol"},{"key":"4007_CR33","doi-asserted-by":"publisher","DOI":"10.3390\/nu14102140","author":"Y Ding","year":"2022","unstructured":"Ding Y, Xu X, Tian T, Yu C, Ge X, Gao J, Lu J, et al. Weight change across adulthood in relation to non-alcoholic fatty liver disease among non-obese individuals. Nutrients. 2022. https:\/\/doi.org\/10.3390\/nu14102140.","journal-title":"Nutrients"},{"key":"4007_CR34","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1186\/s13098-022-00930-w","volume":"14","author":"Y Lin","year":"2022","unstructured":"Lin Y, Feng X, Cao X, Miao R, Sun Y, Li R, Ye J, et al. Age patterns of nonalcoholic fatty liver disease incidence: heterogeneous associations with metabolic changes. Diabetol Metab Syndr. 2022;14:181.","journal-title":"Diabetol Metab Syndr"},{"key":"4007_CR35","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.exger.2013.05.059","volume":"48","author":"Z Wang","year":"2013","unstructured":"Wang Z, Xu M, Peng J, Jiang L, Hu Z, Wang H, Zhou S, et al. Prevalence and associated metabolic factors of fatty liver disease in the elderly. Exp Gerontol. 2013;48:705\u20139.","journal-title":"Exp Gerontol"},{"key":"4007_CR36","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.exger.2016.02.013","volume":"86","author":"AK Palmer","year":"2016","unstructured":"Palmer AK, Kirkland JL. Aging and adipose tissue: potential interventions for diabetes and regenerative medicine. Exp Gerontol. 2016;86:97\u2013105.","journal-title":"Exp Gerontol"},{"key":"4007_CR37","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.cmet.2010.11.004","volume":"12","author":"HY Lee","year":"2010","unstructured":"Lee HY, Choi CS, Birkenfeld AL, Alves TC, Jornayvaz FR, Jurczak MJ, Zhang D, et al. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metab. 2010;12:668\u201374.","journal-title":"Cell Metab"},{"key":"4007_CR38","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1126\/science.1082889","volume":"300","author":"KF Petersen","year":"2003","unstructured":"Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, et al. Mitochondrial dysfunction in the elderly: possible role in insulin resistance. Science. 2003;300:1140\u20132.","journal-title":"Science"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-023-04007-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-023-04007-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,23]],"date-time":"2023-02-23T15:03:31Z","timestamp":1677164611000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-023-04007-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,23]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["4007"],"URL":"https:\/\/doi.org\/10.1186\/s12967-023-04007-8","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,23]]},"assertion":[{"value":"13 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"NHANES is conducted by the Centers for Disease Control and Prevention (CDC) and the National Center for Health Statistics (NCHS). The NCHS Research Ethics Review Committee reviewed and approved the NHANES study protocol. All participants signed written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict or competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"142"}}